Close
GS1 Global Healthcare Conference 2026
LiGHT 2026

Industry Updates

FDA Expands Indication of INVOKAMET (canagliflozin/metformin HCl) to Include First-Line Treatment of

Janssen Pharmaceuticals, Inc. announced the U.S. FDA has approved INVOKAMET, a fixed-dose combination therapy of INVOKANA® (canagliflozin) and metformin hydrochloride, for first-line treatment of adults...

Point-of-care ultrasound indispensable for elite sport in Wales

Point-of-care ultrasound is an essential tool for Dr Mark Ridgewell, an early pioneer for sports and exercise medicine (SEM) and, for the past 13 years,...

Varian Medical Systems Announces Plan To Spin Off Imaging Components Business

Imaging Components business will become a new independent publicly traded company, which will be spun off by means of a tax-free distribution to Varian stockholdersSpin-off...

Novartis’ Entresto given strong Class I recommendation in both US and EU heart failure guidelines, l

US guidelines now recommend Entresto as standard of care for HFrEF as an alternative to ACEs or ARBs; call for doctors to switch patients...

FDA approves Boston Scientific Precision Montageโ„ข MRI Spinal Cord Stimulator System

Boston Scientific Corporation announced the launch of the Precision Montage™ MRI Spinal Cord Stimulator (SCS) System after receiving approval from the U.S. Food and Drug...

Novartis starts FortiHFy clinical program to study heart failure

Fortifying Heart Failure clinical evidence and patient quality of life (FortiHFy) is an umbrella clinical program comprising over 40 active or planned trialsย  The...

GE Healthcare and Accenture Target $2 Billion in Lost Revenue Among US Healthcare Providers

GE Healthcare and Accenture introduced a new offering to help improve medical claims processing and related cash flow for healthcare providers. The alliance, targeting medical...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป